Pleural Catheters Versus Thoracoscopic Pleurodesis

Completed

Conditions studied: Lung Cancer

In brief

The goal of this clinical research study is to compare 2 different methods for treating a pleural effusion. Researchers also want to learn how the treatment you receive effects your quality of life (your ability to do the things you like to do and how happy you feel.

Key facts

Study ID

NCT01117740

Run by

M.D. Anderson Cancer Center

People needed

445

Starts

2010-04-01

Expected to finish

2016-04-01

Last updated by the study team

2016-04-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with MPE who are suitable for either pleural catheter placement or thoracoscopic pleurodesis who subsequently have either procedure performed
• Sufficient mental capacity to answer SF-6D and Borg score questions
• Age 18 or older
• Life expectancy > 2 months
• English or Spanish speaking

You may not qualify if…

• Patients undergoing pleurodesis for benign disease (e.g., spontaneous pneumothorax)
• Inability or unwillingness to give informed consent
• Inability to perform phone call follow-up
• Pregnancy
• Previous intrapleural therapy for MPE
• Prior radiation therapy encompassing the entire hemithorax
• Chylous effusions associated with malignant disease
• Bilateral effusions requiring bilateral pleurodesis

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.